Co-Authors
This is a "connection" page, showing publications co-authored by Susanne Muehlschlegel and Marcey Osgood.
Connection Strength
1.966
-
Osgood M, Muehlschlegel S. POINT: Should Continuous Venovenous Hemofiltration Always Be the Preferred Mode of Renal Replacement Therapy for the Patient With Acute Brain Injury? Yes. Chest. 2017 12; 152(6):1109-1111.
Score: 0.601
-
Osgood M, Muehlschlegel S. Rebuttal From Drs Osgood and Muehlschlegel. Chest. 2017 12; 152(6):1114-1115.
Score: 0.601
-
Osgood M, Compton R, Carandang R, Hall W, Kershaw G, Muehlschlegel S. Rapid unexpected brain herniation in association with renal replacement therapy in acute brain injury: caution in the neurocritical care unit. Neurocrit Care. 2015 Apr; 22(2):176-83.
Score: 0.507
-
Chang HYM, Flahive J, Bose A, Goostrey K, Osgood M, Carandang R, Hall W, Muehlschlegel S. Predicting mortality in moderate-severe TBI patients without early withdrawal of life-sustaining treatments including ICU complications: The MYSTIC-score. J Crit Care. 2022 12; 72:154147.
Score: 0.213
-
Silver B, Hamid T, Khan M, Di Napoli M, Behrouz R, Saposnik G, Sarafin JA, Martin S, Moonis M, Henninger N, Goddeau R, Jun-O'Connell A, Cutting SM, Saad A, Yaghi S, Hall W, Muehlschlegel S, Carandang R, Osgood M, Thompson BB, Fehnel CR, Wendell LC, Potter NS, Gilchrist JM, Barton B. 12 versus 24?h bed rest after acute ischemic stroke thrombolysis: a preliminary experience. J Neurol Sci. 2020 Feb 15; 409:116618.
Score: 0.044